Medical prevention of stroke and stroke recurrence in patients with TIA and minor stroke (Q37532590)

20 August 2017

1 reference

title

Medical prevention of stroke and stroke recurrence in patients with TIA and minor stroke (English)

1 reference

20 August 2017

author

Hans-Christoph Diener

series ordinal

3

object named as

Hans-Christoph Diener

1 reference

20 August 2017

2

Christian Weimar

1 reference

20 August 2017

Ralph Weber

1

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 August 2009

1 reference

Expert Opinion on Pharmacotherapy

20 August 2017

published in

1 reference

20 August 2017

volume

10

1 reference

20 August 2017

issue

12

1 reference

20 August 2017

page(s)

1883-1894

1 reference

Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Knowledge and management of transient ischemic attacks among US primary care physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Transient ischemic attack--proposal for a new definition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Short-term prognosis after emergency department diagnosis of TIA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Head Computed Tomography Findings Predict Short-Term Stroke Risk After Transient Ischemic Attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Antiplatelet therapy for secondary prevention of noncardioembolic ischemic stroke: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Aspirin dose for the prevention of cardiovascular disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Dipyridamole plus aspirin versus aspirin alone in secondary prevention after TIA or stroke: a meta-analysis by risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS): A randomized, double-blind, aspirin-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Prasugrel versus clopidogrel in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Prasugrel in the poststroke cohort of the TRITON Trial: the clear and present danger

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Efficacy and Safety of Anticoagulant Treatment in Acute Cardioembolic Stroke: A Meta-Analysis of Randomized Controlled Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Atrial fibrillation, stroke, and acute antithrombotic therapy: analysis of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Secondary stroke prevention with ximelagatran versus warfarin in patients with atrial fibrillation: pooled analysis of SPORTIF III and V clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Patent foramen ovale and cryptogenic stroke in older patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Antiplatelets versus anticoagulation in cervical artery dissection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention: principal results of a prospective randomized controlled study (MOSES).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Telmisartan, ramipril, or both in patients at high risk for vascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Telmisartan to prevent recurrent stroke and cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Treatment of hypertension in patients 80 years of age or older

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Relative effects of statin therapy on stroke and cardiovascular events in men and women: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Statin treatment withdrawal in ischemic stroke: a controlled randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Effects of intensive glucose lowering in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Homocysteine lowering with folic acid and B vitamins in vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Genetic determinants of response to clopidogrel and cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Dabigatran with or without concomitant aspirin compared with warfarin alone in patients with nonvalvular atrial fibrillation (PETRO Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Clopidogrel for the secondary prevention of stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

The Essen stroke risk score predicts recurrent cardiovascular events: a validation within the REduction of Atherothrombosis for Continued Health (REACH) registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656560903048934

10.1517/14656560903048934

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference